vantagebiotrials, Author at Vantage Biotrials

news-homepage-EN, news-pressroom-EN June 13, 2025 vantagebiotrials Comments: 0

Vantage BioTrials Recognized as Finalist for the 2025 Partnership Award

June 11, 2025, Montréal, Canada – Vantage BioTrials is proud to announce that it has been named a finalist for the esteemed 2025 Partnership Award, a prestigious award recognizing outstanding collaborative projects within Quebec’s innovation ecosystem. This accolade celebrates the successful partnership between Vantage BioTrials, Groupe Sorintellis, and the Centre de Recherche Informatique de Montréal (CRIM), underscoring a shared commitment to advancing clinical research through innovatio...

White Papers-FR March 23, 2024 vantagebiotrials Comments: 0

Prioritizing Agility When Choosing a Contract Research Organization

Prioritizing Agility When Choosing a Contract Research Organization Publication date: September 2023 / Download PDFAuthor: Josée Comeau Introduction Throughout the years, the field of clinical research has continued to grow in complexity and has encountered numerous challenges, and although processes have been well established, many of us have settled into a daily routine that maintains the status quo. It’s time for us to move away from traditional practices and introduce a concept that some...

White Papers-FR February 1, 2024 vantagebiotrials Comments: 0

Criteria for Choosing a Great Contract Research Organization (CRO)

Criteria for Choosing a Great Contract Research Organization (CRO) Publication date: February 2024 / Download PDF Author: Viken Bartekian Introduction Outsourcing is often a necessity within the health care industry. Many pharmaceutical, biotechnology and medical device companies rely on outsourcing to Contract Research Organizations (CROs) as part of their strategy to advance to the next stage of clinical trials. As a matter of perspective, the CRO market size is expected to grow by USD 63.35 b...

news-pressroom-EN November 22, 2023 vantagebiotrials Comments: 0

Vantage BioTrials Awarded Phase 1b ARDS Trial

November 1, 2023, Montréal, Canada – Vantage BioTrials, a full-service Contract Research Organization (CRO), has partnered with a US-based biotech to lead all clinical trial management activities of their Phase Ib Dose Escalation followed by Phase II randomized, placebo controlled, blinded end-point trial in patients with Acute Respiratory Distress Syndrome (ARDS), including COVID-19 patients. The dose escalation phase of the study will inform the safety profile of the Sponsor’s Investi...

White Papers-FR September 1, 2023 vantagebiotrials Comments: 0

Prioritizing Agility When Choosing a Contract Research Organization

Prioritizing Agility When Choosing a Contract Research Organization Publication date: September 2023 / Download PDF Author: Josée Comeau Introduction Throughout the years, the field of clinical research has continued to grow in complexity and has encountered numerous challenges, and although processes have been well established, many of us have settled into a daily routine that maintains the status quo. It’s time for us to move away from traditional practices and introduce a concept that some...

news-pressroom-EN August 26, 2023 vantagebiotrials Comments: 0

President of Vantage BioTrials Interviewed by Pharmaboardroom on the State of Clinical Trials in Canada

Vantage BioTrials’ President, Vatche Bartekian, was recently interviewed by Pharmaboardroom on ways that the company focuses on operational excellence with a lean and holistic approach to each project and how they continually advocate for greater visibility for Canada on the international stage and an increase in collaboration within the pharmaceutical industry and regulatory bodies. “What we can observe in Canada is a very diverse CRO landscape, in which each player has found its ow...

news-pressroom-EN August 26, 2023 vantagebiotrials Comments: 0

President of Vantage BioTrials Interviewed by CATALIS on the State of Clinical Trials Industry in Quebec During the COVID-19 Crisis

The future of clinical research after COVID-19 How will this crisis affect the clinical trial industry in Quebec? Just like in other industries, this pandemic, unfortunately, had an immediate impact on the pharmaceutical industry and notably clinical trials. The multiple restrictions limiting physical interactions between people entails many challenges and a multitude of projects that have been curtailed, postponed or even canceled. In the past weeks, we have observed four major problems linked...

events-EN August 22, 2023 vantagebiotrials Comments: 0

DIA Canada Annual Meeting | October 18-19, 2022

Vantage BioTrials’ President, Vatche Bartekian, will be attending the DIA Canada Annual Meeting & will be participating in the plenary session (Transforming Clinical Trial Design) and presenting “Adaptive Design Trials: Logistical Considerations for Clinical Operations” on October 18, 2022 from 3pm – 4:15pm EDT....

events-EN August 22, 2023 vantagebiotrials Comments: 0

SOCRA Annual Conference | September 29 to October 1, 2023

Vantage BioTrials will be attending the SOCRA Annual Conference from September 29 to October 1, 2023. Our President, Vatche Bartekian, will be presenting “Adaptive Design Trials: Logistical Considerations for Clinical Operations”....

events-EN August 22, 2023 vantagebiotrials Comments: 0

CCSQA Annual Meeting | November 3, 2022

Vantage BioTrials will be attending the Canadian Chapter of the Society of Quality Assurance (CCSQA) Annual Meeting on November 3, 2022. If you missed it at another conference, our President, Vatche Bartekian, will again be presenting “Deconstruct Your Clinical Trial to Plan a Positive Outcome: Effective Planning & Communication Strategies”....